Sugi Predict

Sugi Predict / Compounds / SCHEMBL288888

SCHEMBL288888

SCHEMBL288888

CCC(C)CNCC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 1/20 0.41
▸ ACE P12821 1/20 0.41
▸ CPA1 P15085 1/20 0.41
▸ ACE2 Q9BYF1 1/20 0.41
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ HHAT Q5VTY9 2/20 0.38
▸ FFAR3 O14843 2/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ECE1 P42892 1/20 0.34
▸ GABRP O00591 2/20 0.33
▸ GABRD O14764 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL288887 1.00 MME (0.41) MMEACECPA1ACE2MAPT
SCHEMBL26292998 0.82 HHAT (0.35) MAPTALDH1A1TDP1HHATCYP2D6
SCHEMBL19287243 0.82 ALDH1A1 (0.39) MMEACECPA1ACE2MAPT
SCHEMBL28603390 0.82 ALDH1A1 (0.39) MMEACECPA1ACE2MAPT
SCHEMBL24865869 0.80 HHAT (0.35) MAPTHHAT
SCHEMBL164110 0.78 — —
SCHEMBL26229153 0.78 CACNA2D1 (0.41) MMEACECPA1ACE2MAPT
SCHEMBL2553608 0.77 MME (0.37) MMEACECPA1ACE2MAPT
SCHEMBL287612 0.76 — —
SCHEMBL287613 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117214314-B Organic acid content detection box and detection method 深圳爱湾智造科技有限公司 2024-06-07 — — CN claimed
CN-117214314-A Organic acid content detection box and detection method 深圳爱湾智造科技有限公司 2023-12-12 — — CN claimed
EP-2836485-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2018-01-10 — — EP claimed
US-9695191-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2017-07-04 — — US claimed
EP-2499148-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2017-01-18 — — EP claimed
US-9512139-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2016-12-06 — — US claimed
US-20150051183-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2015-02-19 — — US claimed
EP-2836485-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS Polyphor Ag (CH) 2015-02-18 — — EP claimed
EP-2462147-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2014-11-12 — — EP claimed
WO-2013139697-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2013-09-26 — — WO claimed
US-20120270881-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2012-10-25 — — US claimed
EP-2499148-A2 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS Polyphor Ag (CH) 2012-09-19 — — EP claimed
US-20120202821-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2012-08-09 — — US claimed
WO-2011014973-A2 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2011-02-10 — — WO claimed
US-12391799-B2 Peptoid polymers and methods of use X-THERMA, INC. (US) 2025-08-19 — — US disclosed
US-20250185646-A1 NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES X-THERMA, INC. (US) 2025-06-12 — — US disclosed
US-12207647-B2 Supercooling methods for preservation of biological samples X-THERMA, INC. (US) 2025-01-28 — — US disclosed
US-5648338-A PEPTIDE ANTICOAGULANT THROMBOSIS RESEARCH INSTITUTE (GB) 1997-07-15 — — US disclosed
EP-0509080-A1 INHIBITORS AND SUBSTRATES OF THROMBIN ELLERMAN PHARMACEUTICALS LIMITED (GB) 1992-10-21 — — EP disclosed
WO-1992007869-A1 INHIBITORS AND SUBSTRATES OF THROMBIN THROMBOSIS RESEARCH INSTITUTE (GB) 1992-05-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202821-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS HTR2B, MC1R, HTR1A MME 2760/4885ACE 4247/4885CPA1 3400/4885
US-12391799-B2 Peptoid polymers and methods of use IAPP, CUTA, VIP MME 1110/4885ACE 2662/4885CPA1 226/4885
US-20250185646-A1 NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES PPIG, AQP3, AQP1 MME 2630/4885ACE 3604/4885CPA1 496/4885
US-20120270881-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS KCNB1, KCNAB1, KCNMB1 MME 4066/4885ACE 4809/4885CPA1 3563/4885
US-20150051183-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS CTSE, CTSB, CTSS MME 178/4885ACE 407/4885CPA1 81/4885
US-12207647-B2 Supercooling methods for preservation of biological samples PPIG, AQP3, PYGB MME 2746/4885ACE 3404/4885CPA1 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.